Avanos Medical (AVNS) Capital Expenditures Growth (5y) (2018 - 2026)
Avanos Medical (AVNS) Capital Expenditures Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.48% |
| Dec 31, 2025 | -45.54% |
| Sep 30, 2025 | 18.47% |
| Jun 30, 2025 | 9.78% |
| Mar 31, 2025 | 5.20% |
| Dec 31, 2024 | 25.06% |
| Sep 30, 2024 | -15.83% |
| Jun 30, 2024 | -23.76% |
| Mar 31, 2024 | -19.98% |
| Dec 31, 2023 | 19.20% |
| Sep 30, 2023 | -18.28% |
| Jun 30, 2023 | -18.46% |
| Mar 31, 2023 | -16.06% |
| Dec 31, 2022 | 16.65% |
| Sep 30, 2022 | -17.66% |
| Jun 30, 2022 | -8.52% |
| Mar 31, 2022 | -13.29% |
| Dec 31, 2021 | 18.08% |
| Sep 30, 2021 | -8.78% |
| Jun 30, 2021 | -1.00% |